Aquamarine Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 52.24%
(FY 2022)
- Profit -378.69%
(FY 2022)
- Ebitda -388.82%
(FY 2022)
- Net Worth -1.28%
(FY 2022)
- Total Assets 85.36%
(FY 2022)
About Aquamarine Healthcare
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhishek Gupta and Ajay Bhadu serve as directors at the Company.
- CIN/LLPIN
U52100DL2011PTC222458
- Company No.
222458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
What products or services does Aquamarine Healthcare Private Limited offer?
Aquamarine Healthcare Private Limited offers a wide range of products and services, including Ind Chem, Extra Mileage Booster, Dye, 2 Amino Phenol, Hair, Weight Gain Program, Nutritional Supplements, Weight Loss Nutrition, Weight Loss Programs, Sports Supplement.
Who are the key members and board of directors at Aquamarine Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Bhadu  | Director | 30-Jul-2021 | Current |
| Abhishek Gupta | Director | 31-Aug-2021 | Current |
Financial Performance and Corporate Structure Insights of Aquamarine Healthcare.
Aquamarine Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 52.24% increase. The company also saw a substantial fall in profitability, with a 378.69% decrease in profit. The company's net worth dipped by a decrease of 1.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aquamarine Healthcare?
In 2022, Aquamarine Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Impact Sare Magnum Townships Private LimitedActive 17 years 4 monthsAbhishek Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aquamarine Healthcare?
Aquamarine Healthcare has a workforce of 2 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquamarine Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquamarine Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
